OncoSec Medical Incorporated (ONCS): Price and Financial Metrics

OncoSec Medical Incorporated (ONCS): $0.28

0.07 (+31.87%)

POWR Rating

Component Grades








Add ONCS to Watchlist
Sign Up

Industry: Biotech




#218 of 376

in industry

ONCS Price/Volume Stats

Current price $0.28 52-week high $20.46
Prev. close $0.21 52-week low $0.18
Day low $0.25 Volume 52,491,000
Day high $0.40 Avg. volume 2,219,449
50-day MA $0.63 Dividend yield N/A
200-day MA $3.69 Market Cap 1.26M

ONCS Stock Price Chart Interactive Chart >

OncoSec Medical Incorporated (ONCS) Company Bio

OncoSec Medical Inc. provides biomedical services. The Company focuses on commercializing therapeutic oncology products. OncoSec Medical offers patients with alternative treatments to existing therapies to treat cancerous tumors and cancerous cells.

ONCS Latest News Stream

Event/Time News Detail
Loading, please wait...

ONCS Latest Social Stream

Loading social stream, please wait...

View Full ONCS Social Stream

Latest ONCS News From Around the Web

Below are the latest news stories about ONCOSEC MEDICAL INC that investors may wish to consider to help them evaluate ONCS as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start breaking down the biggest pre-market movers for Thursday as we get ready for another busy day of trading!

William White on InvestorPlace | June 15, 2023

Why Are Chinese Stocks BABA, JD, PDD Up Today?

Chinese stocks are on the rise Thursday as investors react to Alibaba (BABA) expansion plans and lowered interest rates.

William White on InvestorPlace | June 15, 2023

Why Is OncoSec Medical (ONCS) Stock Down 48% Today?

OncoSec Medical (ONCS) stock is falling hard on Thursday after the clinical-stage biotechnology company filed for bankruptcy.

William White on InvestorPlace | June 15, 2023

XPEV Stock Alert: Xpeng Expands Assisted Driving Tech

Xpeng (XPEV) stock is on the move Thursday after the Chinese EV company expanded its assisted driving technology to Beijing.

William White on InvestorPlace | June 15, 2023

OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,408,384 shares of its common stock, at a purchase price of $0.945 per share, priced at-the-market under Nasdaq rules. The Company also issued in a concurrent private placem

Yahoo | May 18, 2023

Read More 'ONCS' Stories Here

ONCS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -72.82%
3-year -99.73%
5-year -99.78%
2023 0.00%
2022 -92.04%
2021 -85.12%
2020 256.35%
2019 -71.72%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!